EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Myeloid Sarcoma

Mohamed Magdy, Nagla Abdel Karim, Ihab Eldessouki, Ola Gaber, Mohamed Rahouma, Mohamed Ghareeb

Oncology Research and Treatment · 2019 · 42 (4) · 219-224

DOI: 10.1159/000497210 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Oncology Research and Treatment, online erschienen am 06.03.2019. Verfasst von Mohamed Magdy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Oncology, Pediatric Hospital, Cairo, Egypt. Die Arbeit wurde bisher 102-mal zitiert (Crossref) und nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematological malignancies can manifest as extramedullary soft tissue masses in relatively rare cases. The rarity of it causes a diagnostic and therapeutic challenge. One of the rarest manifestations is myeloid sarcoma (MS). MS develops as part of acute myeloid leukemia, myeloproliferative neoplasm, or myelodysplastic syndrome or at relapse, especially following allogeneic hematopoietic stem cell transplant. The tumor displays high myeloperoxidase expression, hence the color green, and is called chloroma. It most commonly appears in lymph nodes, skin and soft tissues, bone, testes, gastrointestinal tract, and peritoneum. Immunohistochemistry shows CD68-KP1 as the most commonly expressed marker, then myeloperoxidase, CD117, CD99, CD68/PG-M1, lysozyme, CD34, terminal deoxynucleotidyl transferase, CD56, CD61, CD30, glycophorin A, and CD4. Different chromosomal abnormalities including MLL rearrangement, t(8; 21), monosomy 7, trisomy 8, trisomy 11, trisomy 4, inversion (16), monosomy 16,16q deletion, 5q deletion, and 20q deletion were reported. Most of the literature about MS are case reports and small retrospective studies, thus there is limited clinical knowledge of the cases and their presentation and management plans. Here, we provide a review of what has been reported in the literature about MS in the light of our experiences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FemaleHematopoietic Stem Cell TransplantationHumansImmunohistochemistryLeukemia, Myeloid, AcuteMaleSarcoma, Myeloid

Stichwörter der Autor:innen

ChloromaExtramedullary soft tissue massesMyeloid sarcomaSarcoma

Autor:innen und Institutionen

  • Department of Pediatric Oncology, Pediatric Hospital, Cairo, Egypt.
  • Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio, USA.
  • Department of Surgical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Department of Medical Oncology, National Cancer Institute, Cairo University, Cairo, Egypt.

Zitieren

APA

Magdy, M., Abdel Karim, N., Eldessouki, I., Gaber, O., Rahouma, M., & Ghareeb, M. (2019). Myeloid Sarcoma. Oncology Research and Treatment, 42(4), 219-224. https://doi.org/10.1159/000497210

Vancouver

Magdy M, Abdel Karim N, Eldessouki I, Gaber O, Rahouma M, Ghareeb M. Myeloid Sarcoma. Oncology Research and Treatment. 2019;42(4):219-224. doi:10.1159/000497210

BibTeX
@article{Magdy2019,
  author = {Magdy, Mohamed and Abdel Karim, Nagla and Eldessouki, Ihab and Gaber, Ola and Rahouma, Mohamed and Ghareeb, Mohamed},
  title = {Myeloid Sarcoma},
  journal = {Oncology Research and Treatment},
  year = {2019},
  volume = {42},
  number = {4},
  pages = {219--224},
  doi = {10.1159/000497210}
}
Kostenlos starten →